Pacific Edge eyes Medicare comeback with $24m raise, directors pledge support
Bladder cancer testing company Pacific Edge wants $24 million from inv estors to fund it to regain Medicare coverage in the US. The company entered a trading halt on Monday morning after it said it was undertaking a 17 cents per sh are placement, including $18m to e ligible investors and a further $6m to retail investors, with the option of accepting over-subscriptions.